Kiniksa Pharmaceuticals KNSA reported its Q2 earnings results on Wednesday, August 3, 2022.
Here's what investors need to know about the announcement.
Earnings
Kiniksa Pharmaceuticals beat estimated earnings by 34.09%, reporting an EPS of $-0.29 versus an estimate of $-0.44.
Revenue was up $19.27 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.05 which was followed by a 2.18% drop in the share price the next day.
Here's a look at Kiniksa Pharmaceuticals's past performance:
Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
---|---|---|---|---|
EPS Estimate | -0.41 | -0.42 | -0.65 | -0.79 |
EPS Actual | -0.36 | -0.53 | -0.44 | -0.61 |
Revenue Estimate | 22.77M | 20.72M | 10.18M | 3.97M |
Revenue Actual | 32.19M | 18.75M | 12.10M | 7.70M |
To track all earnings releases for Kiniksa Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.